Previous Close | 15.25 |
Open | 15.10 |
Bid | 15.15 |
Ask | 15.45 |
Strike | 80.00 |
Expire Date | 2025-01-17 |
Day's Range | 15.10 - 15.25 |
Contract Range | N/A |
Volume | |
Open Interest | 1.83k |
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.